Selected research
Industry Growth & Trends
Global Short-acting Nicotine Replacement Industry Growth and Trends Forecast to 2032
Market perspective
The global Short-acting Nicotine Replacement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Short-acting Nicotine Replacement is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Short-acting Nicotine Replacement is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Short-acting Nicotine Replacement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Short-acting Nicotine Replacement include Nicorette (Johnson & Johnson), Nicotinell (Haleon), Equate (Walmart), Thrive (Haleon), NiQuitin (Perrigo), Philip Morris, Alkalon, LUCY GOODS and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Short-acting Nicotine Replacement market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Short-acting Nicotine Replacement market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Short-acting Nicotine Replacement market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Short-acting Nicotine Replacement.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Short-acting Nicotine Replacement market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Short-acting Nicotine Replacement Market by Company
Nicorette (Johnson & Johnson)
Nicotinell (Haleon)
Equate (Walmart)
Thrive (Haleon)
NiQuitin (Perrigo)
Philip Morris
Alkalon
LUCY GOODS
Dr. Reddy's Laboratories
Nicotex (Cipla Health)
Swedish Match
Altria
British American Tobacco (BAT)
Skruf Snus
Japan Tobacco International (JTI)
Short-acting Nicotine Replacement Segment by Type
Nicotine Gum
Nicotine Lozenge
Nasal Spray
Oral Inhaler
Nicotine Pouches
Short-acting Nicotine Replacement Segment by Application
Online Sales
Offline Sales
Short-acting Nicotine Replacement Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-acting Nicotine Replacement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Short-acting Nicotine Replacement and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-acting Nicotine Replacement.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Short-acting Nicotine Replacement manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Short-acting Nicotine Replacement in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Nicotine Gum
- Nicotine Lozenge
- Nasal Spray
- Oral Inhaler
- Nicotine Pouches
Applications
- Online Sales
- Offline Sales
Companies covered
- Nicorette (Johnson & Johnson)
- Nicotinell (Haleon)
- Equate (Walmart)
- Thrive (Haleon)
- NiQuitin (Perrigo)
- Philip Morris
- Alkalon
- LUCY GOODS
- Dr. Reddy's Laboratories
- Nicotex (Cipla Health)
- Swedish Match
- Altria
- British American Tobacco (BAT)
- Skruf Snus
- Japan Tobacco International (JTI)
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Short-acting Nicotine Replacement Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Short-acting Nicotine Replacement Sales Estimates and Forecasts (2021-2032)
- 1.3 Short-acting Nicotine Replacement Market by Type
- 1.3.1 Nicotine Gum
- 1.3.2 Nicotine Lozenge
- 1.3.3 Nasal Spray
- 1.3.4 Oral Inhaler
- 1.3.5 Nicotine Pouches
- 1.4 Global Short-acting Nicotine Replacement Market Size by Type
- 1.4.1 Global Short-acting Nicotine Replacement Market Size Overview by Type (2021-2032)
- 1.4.2 Global Short-acting Nicotine Replacement Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Short-acting Nicotine Replacement Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Short-acting Nicotine Replacement Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Short-acting Nicotine Replacement Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Short-acting Nicotine Replacement Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Short-acting Nicotine Replacement Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Short-acting Nicotine Replacement Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Short-acting Nicotine Replacement Industry Trends
- 2.2 Short-acting Nicotine Replacement Industry Drivers
- 2.3 Short-acting Nicotine Replacement Industry Opportunities and Challenges
- 2.4 Short-acting Nicotine Replacement Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Short-acting Nicotine Replacement Revenue (2021-2026)
- 3.2 Global Top Players by Short-acting Nicotine Replacement Sales (2021-2026)
- 3.3 Global Top Players by Short-acting Nicotine Replacement Price (2021-2026)
- 3.4 Global Short-acting Nicotine Replacement Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Short-acting Nicotine Replacement Major Company Production Sites & Headquarters
- 3.6 Global Short-acting Nicotine Replacement Company, Product Type & Application
- 3.7 Global Short-acting Nicotine Replacement Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Short-acting Nicotine Replacement Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Short-acting Nicotine Replacement Players Market Share by Revenue in 2025
- 3.8.3 2025 Short-acting Nicotine Replacement Tier 1, Tier 2, and Tier 3
4 Short-acting Nicotine Replacement Regional Status and Outlook
- 4.1 Global Short-acting Nicotine Replacement Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Short-acting Nicotine Replacement Historic Market Size by Region
- 4.2.1 Global Short-acting Nicotine Replacement Sales in Volume by Region (2021-2026)
- 4.2.2 Global Short-acting Nicotine Replacement Sales in Value by Region (2021-2026)
- 4.2.3 Global Short-acting Nicotine Replacement Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Short-acting Nicotine Replacement Forecasted Market Size by Region
- 4.3.1 Global Short-acting Nicotine Replacement Sales in Volume by Region (2027-2032)
- 4.3.2 Global Short-acting Nicotine Replacement Sales in Value by Region (2027-2032)
- 4.3.3 Global Short-acting Nicotine Replacement Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Short-acting Nicotine Replacement by Application
- 5.1 Short-acting Nicotine Replacement Market by Application
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Short-acting Nicotine Replacement Market Size by Application
- 5.2.1 Global Short-acting Nicotine Replacement Market Size Overview by Application (2021-2032)
- 5.2.2 Global Short-acting Nicotine Replacement Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Short-acting Nicotine Replacement Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Short-acting Nicotine Replacement Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Short-acting Nicotine Replacement Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Short-acting Nicotine Replacement Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Short-acting Nicotine Replacement Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Short-acting Nicotine Replacement Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Nicorette (Johnson & Johnson)
- 6.1.1 Nicorette (Johnson & Johnson) Company Information
- 6.1.2 Nicorette (Johnson & Johnson) Business Overview
- 6.1.3 Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Nicorette (Johnson & Johnson) Short-acting Nicotine Replacement Product Portfolio
- 6.1.5 Nicorette (Johnson & Johnson) Recent Developments
- 6.2 Nicotinell (Haleon)
- 6.2.1 Nicotinell (Haleon) Company Information
- 6.2.2 Nicotinell (Haleon) Business Overview
- 6.2.3 Nicotinell (Haleon) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Nicotinell (Haleon) Short-acting Nicotine Replacement Product Portfolio
- 6.2.5 Nicotinell (Haleon) Recent Developments
- 6.3 Equate (Walmart)
- 6.3.1 Equate (Walmart) Company Information
- 6.3.2 Equate (Walmart) Business Overview
- 6.3.3 Equate (Walmart) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Equate (Walmart) Short-acting Nicotine Replacement Product Portfolio
- 6.3.5 Equate (Walmart) Recent Developments
- 6.4 Thrive (Haleon)
- 6.4.1 Thrive (Haleon) Company Information
- 6.4.2 Thrive (Haleon) Business Overview
- 6.4.3 Thrive (Haleon) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Thrive (Haleon) Short-acting Nicotine Replacement Product Portfolio
- 6.4.5 Thrive (Haleon) Recent Developments
- 6.5 NiQuitin (Perrigo)
- 6.5.1 NiQuitin (Perrigo) Company Information
- 6.5.2 NiQuitin (Perrigo) Business Overview
- 6.5.3 NiQuitin (Perrigo) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 NiQuitin (Perrigo) Short-acting Nicotine Replacement Product Portfolio
- 6.5.5 NiQuitin (Perrigo) Recent Developments
- 6.6 Philip Morris
- 6.6.1 Philip Morris Company Information
- 6.6.2 Philip Morris Business Overview
- 6.6.3 Philip Morris Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Philip Morris Short-acting Nicotine Replacement Product Portfolio
- 6.6.5 Philip Morris Recent Developments
- 6.7 Alkalon
- 6.7.1 Alkalon Company Information
- 6.7.2 Alkalon Business Overview
- 6.7.3 Alkalon Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Alkalon Short-acting Nicotine Replacement Product Portfolio
- 6.7.5 Alkalon Recent Developments
- 6.8 LUCY GOODS
- 6.8.1 LUCY GOODS Company Information
- 6.8.2 LUCY GOODS Business Overview
- 6.8.3 LUCY GOODS Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 LUCY GOODS Short-acting Nicotine Replacement Product Portfolio
- 6.8.5 LUCY GOODS Recent Developments
- 6.9 Dr. Reddy's Laboratories
- 6.9.1 Dr. Reddy's Laboratories Company Information
- 6.9.2 Dr. Reddy's Laboratories Business Overview
- 6.9.3 Dr. Reddy's Laboratories Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Dr. Reddy's Laboratories Short-acting Nicotine Replacement Product Portfolio
- 6.9.5 Dr. Reddy's Laboratories Recent Developments
- 6.10 Nicotex (Cipla Health)
- 6.10.1 Nicotex (Cipla Health) Company Information
- 6.10.2 Nicotex (Cipla Health) Business Overview
- 6.10.3 Nicotex (Cipla Health) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Nicotex (Cipla Health) Short-acting Nicotine Replacement Product Portfolio
- 6.10.5 Nicotex (Cipla Health) Recent Developments
- 6.11 Swedish Match
- 6.11.1 Swedish Match Company Information
- 6.11.2 Swedish Match Business Overview
- 6.11.3 Swedish Match Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Swedish Match Short-acting Nicotine Replacement Product Portfolio
- 6.11.5 Swedish Match Recent Developments
- 6.12 Altria
- 6.12.1 Altria Company Information
- 6.12.2 Altria Business Overview
- 6.12.3 Altria Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Altria Short-acting Nicotine Replacement Product Portfolio
- 6.12.5 Altria Recent Developments
- 6.13 British American Tobacco (BAT)
- 6.13.1 British American Tobacco (BAT) Company Information
- 6.13.2 British American Tobacco (BAT) Business Overview
- 6.13.3 British American Tobacco (BAT) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 British American Tobacco (BAT) Short-acting Nicotine Replacement Product Portfolio
- 6.13.5 British American Tobacco (BAT) Recent Developments
- 6.14 Skruf Snus
- 6.14.1 Skruf Snus Company Information
- 6.14.2 Skruf Snus Business Overview
- 6.14.3 Skruf Snus Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Skruf Snus Short-acting Nicotine Replacement Product Portfolio
- 6.14.5 Skruf Snus Recent Developments
- 6.15 Japan Tobacco International (JTI)
- 6.15.1 Japan Tobacco International (JTI) Company Information
- 6.15.2 Japan Tobacco International (JTI) Business Overview
- 6.15.3 Japan Tobacco International (JTI) Short-acting Nicotine Replacement Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Japan Tobacco International (JTI) Short-acting Nicotine Replacement Product Portfolio
- 6.15.5 Japan Tobacco International (JTI) Recent Developments
7 North America by Country
- 7.1 North America Short-acting Nicotine Replacement Sales by Country
- 7.1.1 North America Short-acting Nicotine Replacement Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Short-acting Nicotine Replacement Sales by Country (2021-2026)
- 7.1.3 North America Short-acting Nicotine Replacement Sales Forecast by Country (2027-2032)
- 7.2 North America Short-acting Nicotine Replacement Market Size by Country
- 7.2.1 North America Short-acting Nicotine Replacement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Short-acting Nicotine Replacement Market Size by Country (2021-2026)
- 7.2.3 North America Short-acting Nicotine Replacement Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Short-acting Nicotine Replacement Sales by Country
- 8.1.1 Europe Short-acting Nicotine Replacement Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Short-acting Nicotine Replacement Sales by Country (2021-2026)
- 8.1.3 Europe Short-acting Nicotine Replacement Sales Forecast by Country (2027-2032)
- 8.2 Europe Short-acting Nicotine Replacement Market Size by Country
- 8.2.1 Europe Short-acting Nicotine Replacement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Short-acting Nicotine Replacement Market Size by Country (2021-2026)
- 8.2.3 Europe Short-acting Nicotine Replacement Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Short-acting Nicotine Replacement Sales by Country
- 9.1.1 Asia-Pacific Short-acting Nicotine Replacement Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Short-acting Nicotine Replacement Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Short-acting Nicotine Replacement Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Short-acting Nicotine Replacement Market Size by Country
- 9.2.1 Asia-Pacific Short-acting Nicotine Replacement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Short-acting Nicotine Replacement Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Short-acting Nicotine Replacement Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Short-acting Nicotine Replacement Sales by Country
- 10.1.1 South America Short-acting Nicotine Replacement Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Short-acting Nicotine Replacement Sales by Country (2021-2026)
- 10.1.3 South America Short-acting Nicotine Replacement Sales Forecast by Country (2027-2032)
- 10.2 South America Short-acting Nicotine Replacement Market Size by Country
- 10.2.1 South America Short-acting Nicotine Replacement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Short-acting Nicotine Replacement Market Size by Country (2021-2026)
- 10.2.3 South America Short-acting Nicotine Replacement Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Short-acting Nicotine Replacement Sales by Country
- 11.1.1 Middle East and Africa Short-acting Nicotine Replacement Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Short-acting Nicotine Replacement Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Short-acting Nicotine Replacement Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Short-acting Nicotine Replacement Market Size by Country
- 11.2.1 Middle East and Africa Short-acting Nicotine Replacement Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Short-acting Nicotine Replacement Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Short-acting Nicotine Replacement Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Short-acting Nicotine Replacement Value Chain Analysis
- 12.1.1 Short-acting Nicotine Replacement Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Short-acting Nicotine Replacement Production Mode & Process
- 12.2 Short-acting Nicotine Replacement Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Short-acting Nicotine Replacement Distributors
- 12.2.3 Short-acting Nicotine Replacement Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst